Your browser doesn't support javascript.
loading
Use of Cost-Effectiveness Thresholds in Healthcare Public Policy: Progress and Challenges.
Espinosa, Oscar; Rodríguez-Lesmes, Paul; Romano, Giancarlo; Orozco, Esteban; Basto, Sergio; Ávila, Diego; Mesa, Lorena; Enríquez, Hernán.
Afiliação
  • Espinosa O; Economic Models and Quantitative Methods Research Group, Centro de Investigaciones para el Desarrollo, Universidad Nacional de Colombia and Directorate of Analytical, Economic and Actuarial Studies in Health, Instituto de Evaluación Tecnológica en Salud (IETS), Bogotá, DC, Colombia.
  • Rodríguez-Lesmes P; School of Economics, Universidad del Rosario, Bogotá, DC, Colombia. paul.rodriguez@urosario.edu.co.
  • Romano G; Directorate of Analytical, Economic and Actuarial Studies in Health, Instituto de Evaluación Tecnológica en Salud (IETS), Bogotá, DC, Colombia.
  • Orozco E; Directorate of Analytical, Economic and Actuarial Studies in Health, Instituto de Evaluación Tecnológica en Salud (IETS), Bogotá, DC, Colombia.
  • Basto S; School of Economics, Universidad de Antioquia, Bogotá, DC, Colombia.
  • Ávila D; Directorate of Analytical, Economic and Actuarial Studies in Health, Instituto de Evaluación Tecnológica en Salud (IETS), Bogotá, DC, Colombia.
  • Mesa L; Economic Models and Quantitative Methods Research Group, Centro de Investigaciones para el Desarrollo, Universidad Nacional de Colombia and Directorate of Analytical, Economic and Actuarial Studies in Health, Instituto de Evaluación Tecnológica en Salud (IETS), Bogotá, DC, Colombia.
  • Enríquez H; Directorate of Qualitative Methods and Social Research, Instituto de Evaluación Tecnológica en Salud (IETS), Duitama, Colombia.
Appl Health Econ Health Policy ; 22(6): 797-804, 2024 Nov.
Article em En | MEDLINE | ID: mdl-38995492
ABSTRACT
The article offers a comparative analysis of the influence of cost-effectiveness thresholds in the decision-making processes in financing policies, coverage, and price regulation of health technologies in nine countries. We investigated whether countries used cost-effectiveness thresholds for public health policy decision making and found that few countries have adopted the cost-effectiveness threshold as an official criterion for financing, reimbursement, or pricing. However, in countries where it is applied, such as Thailand, the results have been very favorable in terms of minimizing health technology prices and ensuring the financial sustainability of the health system. Although the cost-effectiveness threshold has opportunities for improvement, particularly in certain institutional contexts and with adequate participation of the different strategic actors in the formulation of public policy, its potential use and added value are significant in various aspects.
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Análise Custo-Benefício / Política de Saúde Limite: Humans País/Região como assunto: Asia Idioma: En Revista: Appl Health Econ Health Policy Assunto da revista: SAUDE PUBLICA / SERVICOS DE SAUDE Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Colômbia País de publicação: Nova Zelândia
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Análise Custo-Benefício / Política de Saúde Limite: Humans País/Região como assunto: Asia Idioma: En Revista: Appl Health Econ Health Policy Assunto da revista: SAUDE PUBLICA / SERVICOS DE SAUDE Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Colômbia País de publicação: Nova Zelândia